Molecular aggregation by hydrogen bonding in cold-crystallization behavior of mixed nucleobases analyzed by temperature-controlled infrared spectroscopy.

The cold-crystallization behaviors of dodecyl-substituted nucleobases (adenine, uracil, and thymine) were analyzed. The dodecyl derivative from uracil alone did not exhibit cold crystallization; however, a mixture of adenine and uracil derivatives at a molar ratio of 1 : 1 exhibited cold crystallization. These results are similar to the thermal behavior of dodecyl derivatives of adenine and thymine alone and in mixtures reported in a previous study. Temperature-controlled infrared spectroscopy was used to observe the molecular assembly states of the liquid, supercooled state, and cold-crystallized compounds. Hydrogen-bonded molecular pairs in the high-temperature liquid state, multiple hydrogen-bonded networks in the supercooled state, and reverse Hoogsteen-type complementary hydrogen bonds in cold-crystallized compounds were observed using infrared spectroscopy. The heterogeneity of the system, due to multiple types of hydrogen bonding, retarded the crystallization rate, resulting in supercooling and cold crystallization. Infrared spectroscopy, which can be used to measure the aggregation state of molecules, including the liquid and supercooled states, is an effective analytical method for clarifying the process of cold crystallization.

Cold crystallization and photo-induced thermal behavior of alkyl-derivatized diarylethene molecules.

The thermal behavior of alkylated diarylethene molecules (2,3-bis(2,4,5-trimethyl-3-thienyl)-N-alkylmaleimides; DAE-Cn) was investigated. DAE-C1 and DAE-C2 exhibited cold crystallization, which is a heat-storage phenomenon. In addition, DAE-Cn showed photoisomerization; the open-ring isomer O-DAE-Cn was formed by visible light irradiation and transformed to the closed-ring isomer C-DAE-Cn by UV light irradiation. X-ray diffraction and optical microscopy analyses revealed that O-DAE-Cn exhibited cold crystallization and C-DAE-Cn showed poor crystallinity. UV irradiation (365 nm) inhibited cold crystallization, and visible light irradiation (525 nm) triggered cold crystallization, suggesting that heat storage by the cold crystallization of DAE-Cn can be photo-controlled.

Alkyl substituent-dependent systematic change in cold crystallization of azo molecules.

The thermal behavior of alkyl-derivatized 1-(2,4-dimethylphenylazo)-4-naphthol and 1-(2,4-dimethylphenylazo)-2-naphthol (2,4-DM-4-Cn and 2,4-DM-2-Cn, respectively) was investigated. The change in the position of the alkyl substituent led to a variation in the thermal behavior, including the cold crystallization, which is a heat-storing phenomenon. In addition, a comprehensive study of the alkyl chain length revealed that 2,4-DM-4-Cn had better crystallinity and exhibited cold crystallization with short alkyl chains. The π-π, C-H⋯N, and C-H⋯π interactions stabilized the crystal structure of 2,4-DM-4-Cn. On the other hand, the polymorphism of 2,4-DM-2-Cn inhibited the formation of a uniform crystalline phase during cooling, which led to poor crystallinity. The only difference between the compounds, the position of the substituent, resulted in a clear variation in the cold crystallization and heat storage properties.

Effect of colestimide on the concentrations of polychlorinated dibenzo-p-dioxins, polychlorinated dizenzofurans, and polychlorinated biphenyls in blood of Yusho patients.

BACKGROUND: Oral colestimide was reported to lower the concentration of PCDDs, PCDFs, and PCB in the blood of humans. A pilot study showed that the arithmetic mean total TEQ concentrations of PCDDs, PCDFs, and PCBs in the blood of subjects after the trial decreased approximately 20 % compared to pre-trial levels, suggesting that colestimide could decrease human dioxin levels. We designed the current clinical trial study based on this information. In this study, we examined whether colestimide could reduce the individual congener concentrations of PCDDs, PCDFs, and PCBs in the blood of Yusho patients. METHODS: Out of the 36 Yusho patients who participated in the clinical trial, 26 patients self-administered colestimide 3 g/day orally for 6 months. The concentrations of PCDDs, PCDFs and PCBs in the blood of 26 Yusho patients before the trial were compared with those after the trial. RESULTS: The arithmetic mean total TEQ concentrations of PCDDs, PCDFs, non-ortho PCBs, and mono-ortho PCBs in the blood of the 26 Yusho patients before and after the clinical trial were 42-303 (mean: 130, median: 120) and 43-283 (mean: 132, median: 118) pg TEQ/g lipid, respectively. The sums of the concentrations of 58 PCB congeners measured in the blood of Yusho patients before and after the trial were 321-2643 (mean: 957, median: 872) and 286-2007 (mean: 975, median: 806) ng/g lipid, respectively, indicating that the concentrations of PCDDs, PCDFs, and PCBs after the trial were almost the same as those before the trial. Among congeners of PCDDs, PCDFs, dioxin-like PCBs, and non-dioxin-like PCBs, most congeners of these compounds did not show a statistically significant decrease after the trial. CONCLUSION: Colestimide may not be beneficial in reducing the high blood levels of dioxin-like compounds in Yusho patients.

Surface Structures Formed by a Copper(II) Complex of Alkyl-Derivatized Indigo.

Assembled structures of dyes have great influence on their coloring function. For example, metal ions added in the dyeing process are known to prevent fading of color. Thus, we have investigated the influence of an addition of copper(II) ion on the surface structure of alkyl-derivatized indigo. Scanning tunneling microscope (STM) analysis revealed that the copper(II) complexes of indigo formed orderly lamellar structures on a HOPG substrate. These lamellar structures of the complexes are found to be more stable than those of alkyl-derivatized indigos alone. Furthermore, 2D chirality was observed.